Sign in
4

Changes in Ownership

Nautilus Biotechnology, Inc. Filed Acc 0001378830-25-000003

CEO, President, and Secretary bought 200,000 shares at an average $0.68 ($135,575)

From the SEC's structured data for this filing

Trades in this filing

Patel Sujal M · CEO, President, and Secretary

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2025-09-05 Purchase : show line 1 in the form +116,500 $0.67 $78,544 10,258,221 D
2025-09-08 Purchase : show line 2 in the form +83,500 $0.68 $57,031 10,341,721 D
Open-market purchases · 200,000 sh · avg $0.68 · $135,575
Loading xslF345X05/wk-form4_1757450542.xml…